Evaluation of Galactomannan Enzyme Immunoassay and Quantitative Real-Time PCR for the Diagnosis of Invasive Pulmonary Aspergillosis in a Rat Model
1
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Since there is no consensus about the most reliable assays to detect invasive aspergillosis from samples obtained by minimally invasive or noninvasive methods, we compared the efficacy of an enzyme-linked immunosorbent assay (ELISA) for galactomannan (GM) detection and quantitative real-time PCR assay (qRT-PCR) for the diagnosis of invasive pulmonary aspergillosis. Neutropenic, male Sprague-Dawley rats (specific pathogen free; 8 weeks old; weight, 200 ± 20 g) were immunosuppressed with cyclophosphamide and infected with Aspergillus fumigatus intratracheally. Tissue and whole blood samples were harvested on days 1, 3, 5, and 7 post-infection and examined with GM ELISA and qRT-PCR. The A. fumigatus DNA detection sequence was detected in the following number of samples from 12 immunosuppressed, infected rats examined on the scheduled days: day 1 (0/12), day 3 (0/12), day 5 (6/12), and day 7 (8/12) post-infection. The sensitivity and specificity of the qRT-PCR assay was 29.2% and 100%, respectively. Receiver operating characteristic curve (ROC) analysis indicated a Ct (cycle threshold) cut-off value of 15.35, and the area under the curve (AUC) was 0.627. The GM assay detected antigen in sera obtained on day 1 (5/12), day 3 (9/ 12), day 5 (12/12), and day 7 (12/12) post-infection, and thus had a sensitivity of 79.2% and a specificity of 100%. The ROC of the GM assay indicated that the optimal Ct cut-off value was 1.40 (AUC, 0.919). The GM assay was more sensitive than the qRT-PCR assay in diagnosing invasive pulmonary aspergillosis in rats.
Abstract
Since there is no consensus about the most reliable assays to detect invasive aspergillosis from samples obtained by minimally invasive or noninvasive methods, we compared the efficacy of an enzyme-linked immunosorbent assay (ELISA) for galactomannan (GM) detection and quantitative real-time PCR assay (qRT-PCR) for the diagnosis of invasive pulmonary aspergillosis. Neutropenic, male Sprague-Dawley rats (specific pathogen free; 8 weeks old; weight, 200 ± 20 g) were immunosuppressed with cyclophosphamide and infected with Aspergillus fumigatus intratracheally. Tissue and whole blood samples were harvested on days 1, 3, 5, and 7 post-infection and examined with GM ELISA and qRT-PCR. The A. fumigatus DNA detection sequence was detected in the following number of samples from 12 immunosuppressed, infected rats examined on the scheduled days: day 1 (0/12), day 3 (0/12), day 5 (6/12), and day 7 (8/12) post-infection. The sensitivity and specificity of the qRT-PCR assay was 29.2% and 100%, respectively. Receiver operating characteristic curve (ROC) analysis indicated a Ct (cycle threshold) cut-off value of 15.35, and the area under the curve (AUC) was 0.627. The GM assay detected antigen in sera obtained on day 1 (5/12), day 3 (9/ 12), day 5 (12/12), and day 7 (12/12) post-infection, and thus had a sensitivity of 79.2% and a specificity of 100%. The ROC of the GM assay indicated that the optimal Ct cut-off value was 1.40 (AUC, 0.919). The GM assay was more sensitive than the qRT-PCR assay in diagnosing invasive pulmonary aspergillosis in rats.
참고문헌 (28)
- Aquino VR, "The performance of real-time PCR, galactomannan, and fungal culture in the diagnosis of invasive aspergillosis in ventilated patients with chronic obstructive pulmonary disease(COPD)", Mycopathologia, 174, pp.163~169 (2012)
- Becker MJ, "Quantitative galactomannan detection is superior to PCR in diagnosing and monitoring invasive pulmonary aspergillosis in an experimental rat model", J. Clin. Microbiol, 38, pp.1434~1438 (2000)
- Chamilos G, "Invasive fungal infections in patients with hematologic malignancies in a tertiary care cancer center : an autopsy study over a 15-year period(1989-2003)", Haematologica, 91, pp.986~989 (2006)
- Groll AH, "Current challenges in the diagnosis and management of invasive fungal infections:report from the 15th International Symposium on Infections in the Immunocompromised Host: Thessaloniki, Greece, 22-25 June 2008", Int. J. Antimicrob. Agents, 33, pp.101~104 (2009)
- Hadrich I, "Clinical utility and prognostic value of galactomannan in neutropenic patients with invasive aspergillosis", Pathol. Biol. (Paris), 60, pp.357~361 (2012)
- Hadrich I, "Comparison of PCR-ELISA and real-time PCR for invasive aspergillosis diagnosis in patients with hematological malignancies", Med. Mycol, 49, pp.489~494 (2011)
- Hahn-Ast C, "Overall survival and fungal infection-related mortality in patients with invasive fungal infection and neutropenia after myelosuppressive chemotherapy in a tertiary care centre from 1995 to 2006", J. Antimicrob. Chemother, 65, pp.761~768 (2010)
- Hoenigl M, "Impact of galactomannan testing on the prevalence of invasive aspergillosis in patients with hematological malignancies", Med. Mycol, 50, pp.266~269 (2012)
- Leeflang MM, "Galactomannan detection for invasive aspergillosis in immunocompromised patients", Cochrane Database Syst. Rev, 8, pp.007394~ (2008)
- Leenders AC, "Liposomal amphotericin B (AmBisome)reduces dissemination of infection as compared with amphotericin B deoxycholate (Fungizone) in a rate model of pulmonary aspergillosis", J. Antimicrob. Chemother, 38, pp.215~225 (1996)
- Lengerova M, "Detection and measurement of fungal burden in a guinea pig model of invasive pulmonary aspergillosis by novel quantitative nested real-time PCR compared with galactomannan and (1,3)-beta-D-glucan detection", J. Clin. Microbiol, 50, pp.602~608 (2012)
- Liu J, "Development of real-time PCR method to detect Aspergillus fumigates", Biotechnology, 19, pp.34~36 (2009)
- Loffler J, "Comparison of different methods for extraction of DNA of fungal pathogens from cultures and blood", J. Clin. Microbiol, 35, pp.3311~3312 (1997)
- Luong ML, "Comparison of an Aspergillus realtime polymerase chain reaction assay with galactomannan testing of bronchoalveolar lavage fluid for the diagnosis of invasive pulmonary aspergillosis in lung transplant recipients", Clin. Infect. Dis, 52, pp.1218~1226 (2011)
- McCulloch E, "Antifungal treatment affects the laboratory diagnosis of invasive aspergillosis", J. Clin. Pathol, 65, pp.83~86 (2012)
- Mennink-Kersten MA, "Detection of circulating galactomannan for the diagnosis and management of invasive aspergillosis", Lancet Infect. Dis, 4, pp.349~357 (2004)
- Millon L, "False-positive Aspergillus real-time PCR assay due to a nutritional supplement in a bone marrow transplant recipient with GVH disease", Med. Mycol, 48, pp.661~664 (2010)
- Ruping MJ, "Current issues in the clinical management of invasive aspergillosis - the AGIHO, DMykG, OGMM and PEG web-based survey and expert consensus conference 2009", Mycoses, 54, pp.557~568 (2011)
- Scotter JM, "Comparison of galactomannan detection, PCR-enzyme-linked immunosorbent assay, and real-time PCR for diagnosis of invasive aspergillosis in a neutropenic rat model and effect of caspofungin acetate", Clin. Diagn. Lab. Immunol, 12, pp.1322~1327 (2005)
- Suarez F, "Detection of circulating Aspergillus fumigatus DNA by real-time PCR assay of large serum volumes improves early diagnosis of invasive aspergillosis in highrisk adult patients under hematologic surveillance", J. Clin. Microbiol, 46, pp.3772~3777 (2008)
- Torelli R, "Diagnosis of invasive aspergillosis by a commercial real-time PCR assay for Aspergillus DNA in bronchoalveolar lavage fluid samples from high-risk patients compared to a galactomannan enzyme immunoassay", J. Clin. Microbiol, 49, pp.4273~4278 (2011)
- von Eiff M, "Pulmonary aspergillosis : early diagnosis improves survival", Respiration, 62, pp.341~347 (1995)
- Walsh TJ, "Detection of galactomannan antigenemia in patients receiving piperacillin-tazobactam and correlations between in vitro, in vivo, and clinical properties of the drugantigen interaction", J. Clin. Microbiol, 42, pp.4744~4748 (2004)
- Walsh TJ, "Molecular detection and speciesspecific identification of medically important Aspergillus species by real-time PCR in experimental invasive pulmonary aspergillosis", J. Clin. Microbiol, 49, pp.4150~4157 (2011)
- White PL, "Evaluation of analytical and preliminary clinical performance of Myconostica MycAssay Aspergillus when testing serum specimens for diagnosis of invasive aspergillosis", J. Clin. Microbiol, 49, pp.2169~2174 (2011)
- Yeo SF, "Current status of nonculture methods for diagnosis of invasive fungal infection", Clin. Microbiol. Rev, 15, pp.465~484 (2002)
- Zhang CR, "An experimental study of the therapeutic effect of interleukin-2 and interleukin-12 with and without amphotericin B on pulmonary fungal infection", Zhonghua Jie He He Hu Xi Za Zhi, 27, pp.234~236 (2004)
- Zhao Y, "Detection of Aspergillus fumigatus in a rat model of invasive pulmonary aspergillosis by real-time nucleic acid sequence-based amplification", J. Clin. Microbiol, 48, pp.1378~1383 (2010)